In Tuesday’s Wall Street session, TG Therapeutics Inc (NASDAQ:TGTX) shares traded at $34.86, down -7.48% from the previous session.
TGTX stock price is now -9.23% away from the 50-day moving average and 16.83% away from the 200-day moving average. The market capitalization of the company currently stands at $5.53B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $50, TD Cowen recently initiated with Buy rating for TG Therapeutics Inc (NASDAQ: TGTX). On August 02, 2023, Goldman Upgraded its previous ‘Sell’ rating to ‘Neutral’ on the stock reducing its target price from $16 to quote $12, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Power Sean A, CFO sold 11,337 shares of the company’s stock on Jan 03 ’25. The stock was sold for $343,443 at an average price of $30.29. Upon completion of the transaction, the CFO now directly owns 670,632 shares in the company, valued at $23.38 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 06 ’25, CFO Power Sean A sold 10,021 shares of the business’s stock. A total of $285,939 was realized by selling the stock at an average price of $28.53. This leaves the insider owning 660,611 shares of the company worth $23.03 million. A total of 9.96% of the company’s stock is owned by insiders.
During the past 12 months, TG Therapeutics Inc has had a low of $15.16 and a high of $46.48. As of last week, the company has a debt-to-equity ratio of 1.07, a current ratio of 6.25, and a quick ratio of 5.03.
The net profit margin was 10.13% and return on equity was 19.70% for TGTX. The company reported revenue of $108.19 million for the quarter, compared to $43.97 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 146.04 percent.
